FDA inspection

Naari Pharma Private Limited: FDA inspection ending Nov 1, 2025

FDA inspection 1289782 · Rudrapur

Key facts

Inspection ID 1289782
Firm Naari Pharma Private Limited
FEI number 3014247908
Address Sector - 5, 55 - 57 Plot No: 14 - 15; Iie
City Rudrapur
Fiscal year 2026
Inspection end date Nov 1, 2025
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections